Author:
Heine Nils,Doll-Nikutta Katharina,Stein Frederic,Jakobi Jurij,Ingendoh-Tsakmakidis Alexandra,Rehbock Christoph,Winkel Andreas,Barcikowski Stephan,Stiesch Meike
Abstract
AbstractStaphylococcus aureus biofilm-associated infections are a common complication in modern medicine. Due to inherent resilience of biofilms to antibiotics and the rising number of antibiotic-resistant bacterial strains, new treatment options are required. For this purpose, ultrapure, spherical silver–gold-alloy nanoparticles with homogenous elemental distribution were synthesized by laser ablation in liquids and analyzed for their antibacterial activity on different stages of S. aureus biofilm formation as well as for different viability parameters. First, the effect of nanoparticles against planktonic bacteria was tested with metabolic activity measurements. Next, nanoparticles were incubated with differently matured S. aureus biofilms, which were then analyzed by metabolic activity measurements and three dimensional live/dead fluorescent staining to determine biofilm volume and membrane integrity. It could be shown that AgAu NPs exhibit antibacterial properties against planktonic bacteria but also against early-stage and even mature biofilms, with a complete diffusion through the biofilm matrix. Furthermore, AgAu NPs primarily targeted metabolic activity, to a smaller extend membrane integrity, but not the biofilm volume. Additional molecular analyses using qRT-PCR confirmed the influence on different metabolic pathways, like glycolysis, stress response and biofilm formation. As this shows clear similarities to the mechanism of pure silver ions, the results strengthen silver ions to be the major antibacterial agent of the synthesized nanoparticles. In summary, the results of this study provide initial evidence of promising anti-biofilm characteristics of silver–gold-alloy nanoparticles and support the importance of further translation-oriented analyses in the future.
Funder
Deutsche Forschungsgemeinschaft
Medizinische Hochschule Hannover (MHH)
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Zimmerli, W. Clinical presentation and treatment of orthopaedic implant-associated infection. J. Internet Med. 276, 111–119 (2014).
2. Romanos, G. E., Javed, F., Delgado-Ruiz, R. A. & Calvo-Guirado, J. L. Peri-implant diseases. Den. Clin. North Am. 59, 157–178 (2015).
3. Kapadia, B. H. et al. Periprosthetic joint infection. Lancet 387, 386–394 (2016).
4. Dreyer, H. et al. Epidemiology and risk factors of peri-implantitis: A systematic review. J. Periodont. Res. 53, 657–681 (2018).
5. Smeets, R. et al. Definition, etiology, prevention and treatment of peri-implantitis – a review. Head Face Med. 10, 34 (2014).